Cargando…
LAMTOR1 degrades MHC-II via the endocytic in hepatocellular carcinoma
Tumor cell surface antigen recognition is a major hallmark of cancer therapy, and loss of major histocompatibility complex class I (MHC-I) is the most common mechanism that impairs tumor cell surface antigen processing and expression. In addition to this, MHC-II regulates antigen presentation in CD4...
Autores principales: | Wu, Bo, Wang, Qian, Li, Bowen, Jiang, Meixi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890926/ https://www.ncbi.nlm.nih.gov/pubmed/36070764 http://dx.doi.org/10.1093/carcin/bgac075 |
Ejemplares similares
-
MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma
por: Wang, Wen, et al.
Publicado: (2012) -
Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice
por: Nishio, Miki, et al.
Publicado: (2020) -
AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2
por: Deng, Peng, et al.
Publicado: (2018) -
A yes-associated protein 1- Notch1 receptor positive feedback loop promotes breast cancer lung metastasis by attenuating the bone morphogenetic protein 4-SMAD family member 1/5 signaling
por: Zhao, Lin, et al.
Publicado: (2022) -
Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3β pathway
por: Gao, Bo, et al.
Publicado: (2020)